GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 9, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

July 31, 2025

Conditions
Relapsed or Refractory Multiple Myeloma (RRMM)Diffuse Large B Cell Lymphoma (DLBCL)Acute Myeloid Leukemia (AML)
Interventions
BIOLOGICAL

GEN3014

GEN3014 is administered by IV infusion.

DRUG

Daratumumab

Daratumumab is administered by SC injections.

Trial Locations (52)

44106

University Hospitals Cleveland Medical Center, Cleveland

53226

Medical college of Wisconsin, Milwaukee

07601

John Theurer Cancer Center, Hackensack

Unknown

Northern Health, Epping

The Alfred Hospital, Melbourne

Royal Prince Alfred Hospital, Sydney

University Clinical Center of the Republic of the Srpska, Banja Luka

Klinika za hematologiju KCUS, Sarajevo

UKC - University Clinical Center Tuzla, Tuzla

Fakultni Nemocnice Brno, Brno

Vseobecna fakultni nemocnice, New Town

Fakultni Nemocnice Hradec Kralove FNHK, Nový Hradec Králové

Fakultni Nemocnice Olomouc (FNOL), Olomouc

FNO - Fakultni nemocnice Ostrava, Poruba

Aalborg Universitet, Aalborg

Vejle Hospital, Vejle

CHRU de Lille, Lille

CHRU de Nantes, Nantes

ARENSIA Exploratory Medicine LLC, Tbilisi

Alexandra General Hospital, Athens

Evangelismos Hospital NKUA, Athens

University General Hospital of Patras, Rio

Ahepa University General hospital, Thessaloniki

Szabolcs-Szatmar-Bereg County Hospitals and University Hospital, Josa Andras University Hospital, Nyíregyháza

Hospital Ampang, Ampang

Hospital Sultanah Aminah, Johor Bahru

Hospital Umum Sarawak, Kuching

Beacon Hospital, Petaling Jaya

Institute of Oncology, ARENSIA Exploratory Medicine, Chisinau

Maastricht UMC, Maastricht

Erasmus MC, Rotterdam

UMC Utrecht, Utrecht

Christchurch Hospital, Christchurch

Auckland Cancer Trials Centre, Grafton

Palmerston North Hospital, Palmerston North

North Shore Hospital, Takapuna

University Clinic of Hematology, Skopje

Makati Medical Center, Makati City

University Centrum Kliniczne, Gdansk

Pratia Onkologia Katowice, Katowice

Pratia MCM, Krakow

Wroclaw Medical University, Wroclaw

Chonnam National University Hwasun Hospital, Gwangju

Pusan National University Hospital PNUH, Pusan

Gachon University Gil Medical Center, Seongnam

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

University of Navarra, Pamplona

University Hospital of Salamanca, Salamanca

Karolinska Institute, Huddinge

Universitetssjukhuset i Lund, Lund

Arensia Exploratory Medicine, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genmab

INDUSTRY